Syros Pharmaceuticals, Inc.
SYRS · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $139,526 | $167,467 | $92,302 | $173,984 |
| Short-Term Investments | $0 | $34,837 | $38,067 | $0 |
| Receivables | $0 | $1,694 | $2,979 | $2,331 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $5,454 | $7,394 | $3,237 | $2,242 |
| Total Curr. Assets | $144,980 | $211,392 | $136,585 | $178,557 |
| Property Plant & Equip (Net) | $19,483 | $24,660 | $27,285 | $29,641 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $2,119 | $3,086 | $13,038 | $3,086 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $1,592 | $5,348 | $6,027 | $1,966 |
| Total NC Assets | $23,194 | $33,094 | $46,350 | $34,693 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $168,174 | $244,486 | $182,935 | $213,250 |
| Liabilities | – | – | – | – |
| Payables | $11,544 | $6,411 | $3,692 | $3,603 |
| Short-Term Debt | $8,991 | $2,071 | $2,011 | $3,456 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $4,330 | $10,181 | $12,209 |
| Other Curr. Liab. | $16,146 | $17,966 | $15,624 | $9,356 |
| Total Curr. Liab. | $36,681 | $30,778 | $31,508 | $28,624 |
| LT Debt | $53,084 | $61,500 | $63,180 | $64,485 |
| Deferred Rev, NC | $0 | $0 | $0 | $9,877 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $61,747 | $24,472 | $3,029 | $19,711 |
| Total NC Liab. | $114,831 | $85,972 | $66,209 | $94,073 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $20,852 | $22,922 | $24,934 | $26,662 |
| Total Liabilities | $151,512 | $116,750 | $97,717 | $122,697 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $26 | $20 | $61 | $56 |
| Retained Earnings | -$722,807 | -$558,233 | -$463,579 | -$377,021 |
| AOCI | $0 | $102 | -$79 | $0 |
| Other Equity | $739,443 | $685,847 | $548,815 | $467,518 |
| Total Equity | $16,662 | $127,736 | $85,218 | $90,553 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $168,174 | $244,486 | $182,935 | $213,250 |
| Net Debt | -$77,451 | -$103,896 | -$27,111 | -$106,043 |